BMJ Best Practice
最后审核时间: 十月 2018
最近更新时间: 一月 2018

小结

定义

病史和查体

关键诊断因素

  • 危险因素的存在
  • 同眠者的陈诉
  • 入睡延迟
  • 多次或长时间觉醒

其他诊断因素

  • 功能受损
  • 事故
  • 睡眠时间缩短
  • 功能受损

危险因素

  • 女性性别
  • 年龄增长
  • 慢性疾病
  • 慢性疼痛(如髋关节损伤)

诊断性检查

首要检查

  • 匹兹堡睡眠质量指数 (PSQI)
  • 失眠严重程度指数 (ISI)
  • 斯坦福嗜睡量表 (SSS)
  • Epworth 嗜睡量表
全部具体信息

需要考虑的检查

  • 多导睡眠图 (PSG)
  • 活动记录仪
  • 睡眠日记
  • 促甲状腺激素(TSH)
全部具体信息

治疗流程

急性
疾病持续状态

贡献者

Teofilo Lee-Chiong MD

Professor of Medicine

Chief, Division of Sleep Medicine

Department of Medicine

National Jewish Health Denver

Professor of Medicine

School of Medicine

University of Colorado

Denver

CO

利益冲突披露
TLC is the Chief Medical Liaison for Philips, a company that makes devices to treat sleep apnea.
Vipin Malik MD

Associate Professor of Medicine

Division of Pulmonary, Critical Care and Sleep Medicine

National Jewish Health Denver

Assistant Professor of Medicine

Pulmonary Sciences and Critical Care Medicine

University of Colorado

Denver

CO

利益冲突披露
VM received research funding from Philips Respironics for a study on COPD-OSA overlap.

同行评议专家 查看所有

Director

Sleep Disorders Center

Thomas Jefferson University Hospital

Philadelphia

PA

利益冲突披露
KD is a speaker for Sanofi-Aventis, King Pharmaceuticals, Takeda Pharmaceuticals, Sepracor, and Pfizer; a consultant for Sanofi-Aventis, Takeda Pharmaceuticals, Sepracor, Pfizer, and Neurocrine Biosciences; and has stock in Merck.

Assistant Professor

Geriatric Psychiatry and Neuropsychiatry

The Johns Hopkins Hospital

Baltimore

MD

利益冲突披露
CUO declares that he has no competing interests.

Medical Director

Kings Harbor Multicare Center

Bronx

NY

利益冲突披露
RG declares that he has no competing interests.

Affiliate Assistant Professor

Department of Psychiatry and Behavioral Sciences

University of Washington Medical Center

Seattle

WA

利益冲突披露
CS declares that he has no competing interests.

Director

Melbourne Sleep Disorders Centre

Melbourne

Victoria

Australia

利益冲突披露
DC has received consulting fees from Sanofi-Aventis and Lundbeck, and honoraria for speaking from Sanofi-Aventis.

使用此内容应接受我们的免责声明